We are live on
!
Find out more
RP
Riverbridge Partners Portfolio holdings
AUM
$3.58B
1-Year Est. Return
4.02%
This Fund
S&P 500
This Quarter
Est. Return
+2.71%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$10.1B
AUM Growth
+$137M
(+1.4%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
27.88%
Holding
173
New
17
Increased
64
Reduced
61
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMED
Amedisys
AMED
|
+$92.7M |
| 2 |
Progyny
PGNY
|
+$45.5M |
| 3 |
Privia Health
PRVA
|
+$44.6M |
| 4 |
SQSP
Squarespace, Inc.
SQSP
|
+$42.6M |
| 5 |
ThredUp
TDUP
|
+$40.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gentex
GNTX
|
+$91.3M |
| 2 |
Maximus
MMS
|
+$39.6M |
| 3 |
Rogers Corp
ROG
|
+$36.3M |
| 4 |
NATI
National Instruments Corp
NATI
|
+$36M |
| 5 |
Healthcare Services Group
HCSG
|
+$35.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.01% |
| 2 | Healthcare | 23% |
| 3 | Industrials | 15.49% |
| 4 | Consumer Discretionary | 8.61% |
| 5 | Communication Services | 4.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Xcel Energy
XEL
$49.2B
| $258K | ﹤0.01% |
3,810
| – | – |
|
152
Union Pacific
UNP
$174B
| $252K | ﹤0.01% |
+1,000
| New | +$237K |
|
153
Hormel Foods
HRL
$14.2B
| $243K | ﹤0.01% |
4,980
| – | – |
|
154
Automatic Data Processing
ADP
$109B
| $240K | ﹤0.01% |
+974
| New | +$221K |
|
155
Lennox International
LII
$15B
| $201K | ﹤0.01% |
+619
| New | +$193K |
|
156
Amcor
AMCR
$21.2B
| $184K | ﹤0.01% |
3,060
| – | – |
|
|
NEUE
157
DELISTED
NeueHealth
NEUE
| $77K | ﹤0.01% |
+281
| New | +$130K |
|
|
PETV
158
DELISTED
PetVivo Holdings, Inc. Common Stock
PETV
| $54K | ﹤0.01% |
14,369
| – | – |
|
159
Inogen
INGN
$174M
| – | – |
-276,881
| Closed | -$11.9M |
|
160
lululemon athletica
LULU
$13.5B
| – | – |
-500
| Closed | -$202K |
|
|
161
Maximus
MMS
$3.32B
| – | – |
-476,069
| Closed | -$39.6M |
|
|
162
Rogers Corp
ROG
$2.08B
| – | – |
-194,449
| Closed | -$36.3M |
|
|
PETQ
163
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| – | – |
-1,172,936
| Closed | -$29.3M |
|
Similar funds
BPS
VPC
WWA
SPC
U
SL
SCM
AAP
Riverbridge Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Riverbridge Partners held 173 positions worth $10.1B, up 1.4% from $9.97B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Riverbridge Partners's Q4 2021 filing shows 17 new, 64 increased, 61 reduced and 5 closed positions. Its largest new stake was Progyny: 812,333 shares worth $40.9M. The largest sale was Gentex, an estimated $91.3M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 39% a quarter earlier, followed by Healthcare and Industrials.
- Riverbridge Partners's largest Q4 2021 buy was Progyny: 812,333 shares worth $40.9M.
- Riverbridge Partners added most to Amedisys in Q4 2021, an estimated $92.7M increase.
- Riverbridge Partners's biggest Q4 2021 reduction was Gentex, cutting an estimated $91.3M.
- Riverbridge Partners fully exited Maximus in Q4 2021, selling an estimated $39.6M.
- Riverbridge Partners's ten largest holdings make up 28% of its $10.1B portfolio in Q4 2021.
- Riverbridge Partners opened 17 new positions and closed 5 in Q4 2021.
- Riverbridge Partners's portfolio value rose 1.4% quarter-over-quarter to $10.1B.
Based on Riverbridge Partners's 13F filing for Q4 2021, filed 14 Jan 2022.